abstract |
The present invention relates to a pharmaceutical composition for prevention or treatment of (psycho)neurologic abnormal behaviors such as bias toward detail-focused processing, cognitive impairment, difficulties with social interaction and communication, hyperactivity, and repetitive behavior, the composition comprising agmatine or a pharmaceutically acceptable salt thereof. |